LEADER 01146nam0-22003371i-450- 001 990003103730403321 010 $a2-11-086736-1 035 $a000310373 035 $aFED01000310373 035 $a(Aleph)000310373FED01 035 $a000310373 100 $a20000920d1991----km-y0itay50------ba 101 0 $aita 102 $aIT 200 1 $aIntégration régional et ajustement structurel en Afrique sub-saharienne$fSous la diréction de Jean Coussy, Philippe Hugon$gavec la collaboration du CERED-LAREA$gCoordination$eSuzanne Quiers-Valette...[et al.]. 210 $aParis$cMinistère de la coopération et du developpement$d1991. 215 $a306 p.$d24 cm 610 0 $aAfrica subsahariana$aIntegrazione regionale 676 $aF/1.12 676 $aO/1.241 702 1$aCoussy,$bJean 702 1$aHugon,$bPhilippe 702 1$aQuiers-Valette,$bSuzanne 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003103730403321 952 $aF/1.12 COU$b12496$fSES 959 $aSES 996 $aIntégration régional et ajustement structurel en Afrique sub-saharienne$9461950 997 $aUNINA DB $aING01 LEADER 01226nam--2200397---450- 001 990001759630203316 005 20101221100133.0 010 $a2-84261-372-4 035 $a000175963 035 $aUSA01000175963 035 $a(ALEPH)000175963USA01 035 $a000175963 100 $a20040616d2002----km-y0enga50------ba 101 0 $afre 102 $aFR 105 $ay---z---001yy 200 1 $aDe quel droit?$eLe droit international humanitaire et les dommages collateraux$fIsabel Vale Majerus 210 $aParis$cle Serpent à plumes$dcopyr. 2002 215 $a228 p.$d18 cm 410 0$12001 454 1 $12001 461 1$1001------$12001 606 0 $aDiritto umanitario internazionale 676 $a341.3 700 1$aMAJERUS,$bIsabel Vale$0563127 801 0$aIT$bsalbc$gISBD 912 $a990001759630203316 951 $aXXIII.1.M. 555 (IG VIII 17 FR 371)$b45425 G.$cXXIII.1.M. 555 (IG VIII 17 FR)$d00116183 959 $aBK 969 $aGIU 979 $aACQUISTI$b10$c20040616$lUSA01$h1016 979 $aIANNONE$b90$c20050714$lUSA01$h1340 979 $aRSIAV5$b90$c20091030$lUSA01$h0953 979 $aRSIAV4$b90$c20101221$lUSA01$h1001 996 $aDe quel droit$9945645 997 $aUNISA LEADER 02146nas 22006373a 450 001 996199952603316 005 20221206145147.0 011 $a1945-0052 035 $a(OCoLC)44992175 035 $a(CKB)111027544563002 035 $a(CONSER)--2008215787 035 $a(EXLCZ)99111027544563002 100 $a20000911a19959999 s-- a 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aR & D directions 210 $aWest Trenton, N.J. $cEngel Pub. Partners $cPublished in cooperation with the American Academy of Pharmaceutical Physicians 300 $aVolumes for 2005- published: Newtown, Pa. : Canon Communications Pharmaceutical Media Group. 311 $a1079-9397 517 3 $aR and D directions 531 $aR&D DIRECTIONS 531 $aR AND D DIRECTION 531 $aRANDD DIRECTIONS 606 $aDrugs$xTesting$vPeriodicals 606 $aDrugs$xResearch$vPeriodicals 606 $aDrugs$xStandards$vPeriodicals 606 $aTherapeutics, Experimental$vPeriodicals 606 $aDrug Evaluation 606 $aPharmaceutical Preparations$xstandards 606 $aDrugs$xResearch$2fast$3(OCoLC)fst00898894 606 $aDrugs$xStandards$2fast$3(OCoLC)fst00898923 606 $aDrugs$xTesting$2fast$3(OCoLC)fst00898940 606 $aTherapeutics, Experimental$2fast$3(OCoLC)fst01149709 608 $aPeriodical 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aDrugs$xTesting 615 0$aDrugs$xResearch 615 0$aDrugs$xStandards 615 0$aTherapeutics, Experimental 615 2$aDrug Evaluation 615 2$aPharmaceutical Preparations$xstandards 615 7$aDrugs$xResearch. 615 7$aDrugs$xStandards. 615 7$aDrugs$xTesting. 615 7$aTherapeutics, Experimental. 676 $a615 712 02$aAmerican Academy of Pharmaceutical Physicians. 712 02$aCanon Communications Pharmaceutical Media Group. 906 $aJOURNAL 912 $a996199952603316 996 $aR & D directions$92577333 997 $aUNISA